Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM72WQ3)

Drug Name

Kodaistatin C Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Glucose-6-phosphate translocase (SLC37A4)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
S 0957	DM9HA8G	Discovery agent	N.A.	Investigative	[2]
S 1743	DMA5GOX	Discovery agent	N.A.	Investigative	[2]
Chlorogenic acid	DM2Y3P4	Discovery agent	N.A.	Investigative	[3]
S-4048	DME5HIR	Discovery agent	N.A.	Investigative	[4]
Kodaistatin A	DMAJKRX	Discovery agent	N.A.	Investigative	[1]
S 3025	DMZN0RW	Discovery agent	N.A.	Investigative	[5]
Mumbaistatin	DM6SYMH	Discovery agent	N.A.	Investigative	[6]
------------------------------------------------------------------------------------


⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Glucose-6-phosphate translocase (SLC37A4)	TT1KPBZ	G6PT1_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Kodaistatins, novel inhibitors of glucose-6-phosphate translocase T1 from Aspergillus terreus thom DSM 11247. Isolation and structural elucidation. J Antibiot (Tokyo). 2000 Jul;53(7):677-86.
2	Identification of protein components of the microsomal glucose 6-phosphate transporter by photoaffinity labelling. Biochem J. 1999 May 1;339 ( Pt 3):629-38.
3	Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase. J Med Chem. 1997 Jan 17;40(2):137-45.
4	Glucose release from GLUT2-null hepatocytes: characterization of a major and a minor pathway. Am J Physiol Endocrinol Metab. 2002 Apr;282(4):E794-801.
5	Prolonged blood glucose reduction in mrp-2 deficient rats (GY/TR(-)) by the glucose-6-phosphate translocase inhibitor S 3025. Biochim Biophys Acta. 2002 Jan 15;1569(1-3):105-10.
6	Studies toward the total synthesis of mumbaistatin, a highly potent glucose-6-phosphate translocase inhibitor. Synthesis of a mumbaistatin analogue. J Org Chem. 2002 Dec 27;67(26):9248-56.